Prescription Pattern and Glycaemic Control Using Glycated Haemoglobin in Type 2 Diabetic Patients: A Cross-Sectional Survey

dc.contributor.authorDavid, E.A
dc.contributor.authorAderemi-Williams, R.I.
dc.contributor.authorSoremekun, R.O
dc.date.accessioned2021-06-04T09:15:39Z
dc.date.available2021-06-04T09:15:39Z
dc.date.issued2020-10
dc.descriptionScholarly Articleen_US
dc.description.abstract Background:- Irrational medication prescribing and paucity of glycated hemoglobin testing in resource limited settings leads to poor health outcomes in patients with type 2 diabetes mellitus  Objectives: This study aims to describe prescription pattern and assess glycaemic control using Glycated hemoglobin among type 2 diabetic patients attending clinic at Abubakar Tafawa Balewa University Teaching Hospital. Bauchi, Nigeria.  Methods: A 6 months prospective, cross sectional, observational survey, conducted in 200 patients with uncontrolled type 2 diabetes mellitus (≥ 7mmol/L fasting blood glucose). Prescribed medications and socio-demographic characteristics were obtained through face-to-face interview, body mass index was computed using weight and height measurements and 4μl sample of capillary blood obtained from finger prick of individual subject was used for Glycated haemoglobin test. Data was analysed using SPSS version 20.0 and results were expressed in descriptive and inferential statistics.  Results: A total of 200 type 2 diabetic patients, with uncontrolled glycaemia participated in the study. Majority were ≥ 40 years (82.5%), female (67.5%), married (86.5%) and engaged in low level of physical activity (81%). About half had no formal education (47%) and 51.5% had family history of diabetes. (Metformin was the most commonly prescribed antidiabetic agents (91.5%), while only 5.5% of the study population received antilipidaemic medication. Furthermore, chi square analysis showed that no factor was associated with uncontrolled glycaemia using Glycated haemoglobin test (P > 0.05).  Conclusion: Insufficient prescribing of antilipidaemic agents was observed and about half (46%) of the participants had controlled glycaemia using Glycated haemoglobin test as against 100% using fasting glucose test. Interprofessional Collaborative care, involving physicians, pharmacists, patients and other health care providers, as well as point-of-care Glycated haemoglobin testing are recommended to ensure rational medication prescribing and improved care outcomesen_US
dc.identifier.citation2. David EA, Aderemi-Williams RI, Soremekun RO (2020) Prescription Pattern and Glycaemic Control Using Glycated Haemoglobin in Type 2 Diabetic Patients: A Cross-Sectional Survey. International Journal of Innovative Science and Research Technology 5 (10): 779-787.en_US
dc.identifier.issn2456-2165
dc.identifier.urihttps://ijisrt.com
dc.identifier.urihttps://ir.unilag.edu.ng/handle/123456789/9439
dc.language.isoenen_US
dc.publisherInternational Journal of Innovative Science and Research Technologyen_US
dc.relation.ispartofseriesInternational Journal of Innovative Science and Research Technology;5(10)
dc.subjectPrescription Patternen_US
dc.subjectAntidiabetesen_US
dc.subjectGlycated Haemoglobinen_US
dc.subjectType 2 Diabetesen_US
dc.subjectNigeriaen_US
dc.subjectResearch Subject Categories::PHARMACY::Other pharmacyen_US
dc.titlePrescription Pattern and Glycaemic Control Using Glycated Haemoglobin in Type 2 Diabetic Patients: A Cross-Sectional Surveyen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Pub 2 Prescription Pattern and Glycaemic Control.pdf
Size:
634.51 KB
Format:
Adobe Portable Document Format
Description:
Full Text
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: